S Uhlig, AN von Bethmann, RL Featherstone and A Wendel
Biochemical Pharmacology, University of Konstanz, Germany.

Endothelin receptor subtypes were characterized in isolated perfused rat lungs using the peptide ETA-receptor antagonists BQ 610 and BQ 123, the nonpeptide mixed ETA-/ETB-receptor antagonist bosentan, and the ETB- receptor agonist IRL 1620. Intra-arterial injection of 1 nmol IRL 1620 caused an enhanced reduction in pulmonary conductance compared with 1 nmol endothelin (ET-1) or 0.33 nmol IRL 1620. Pretreatment of lungs with BQ 610, BQ 123, or bosentan aggravated the bronchoconstriction induced by 1 nmol ET-1 so that it was comparable to that induced by 1 nmol IRL 1620. Although perfusion with 1 nmol IRL 1620 had only minor effects on vascular conductance, 1 nmol ET-1 caused a marked decrease in this parameter. This vasonconstriction was prevented by BQ 610, BQ 123, or bosentan. High concentrations of the stable prostacyclin metabolite, 6-keto-PGF1 alpha, were found in the perfusate of lungs treated with 1 nmol IRL 1620 or 1 nmol ET-1. The ET-1-induced release of 6-keto-PGF1 alpha was blocked by bosentan, but not by BQ 610. ET-1, but not IRL 1620, provoked the release of thromboxane B2. The main effect of ETA-receptor stimulation is vasoconstriction, whereas ETB- receptor stimulation causes bronchoconstriction. Both actions, however, are attenuated by the other receptor, i.e., the ETA-induced vasoconstriction is attenuated by ETB-receptor-induced release of vasodilators such as prostacyclin, whereas the ETB-receptor-induced bronchoconstriction is attenuated by an unknown ETA-receptor-dependent bronchodilatory mechanism.

This article has been cited by other articles:

				E. M. Whitman, S. Pisarcik, T. Luke, M. Fallon, J. Wang, J. T. Sylvester, G. L. Semenza, and L. A. Shimoda Endothelin-1 mediates hypoxia-induced inhibition of voltage-gated K+ channel expression in pulmonary arterial myocytes Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L309 - L318. [Abstract] [Full Text] [PDF]

				J. Y. C. Tsang, W. J. E. Lamm, B. Neradilek, N. L. Polissar, and M. P. Hlastala Endothelin receptor blockade does not improve hypoxemia following acute pulmonary thromboembolism J Appl Physiol, February 1, 2007; 102(2): 762 - 771. [Abstract] [Full Text] [PDF]

				M. Wendel, W. Kummer, L. Knels, J. Schmeck, and T. Koch Muscular ETB Receptors Develop Postnatally and Are Differentially Distributed in Specific Segments of the Rat Vasculature J. Histochem. Cytochem., February 1, 2005; 53(2): 187 - 196. [Abstract] [Full Text] [PDF]

				S. Uhlig Taking a Peep at the Upper Airways Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1026 - 1027. [Full Text]

				R. Goggel, S. Hoffman, R. Nusing, S. Narumiya, and S. Uhlig Platelet-Activating Factor-induced Pulmonary Edema Is Partly Mediated by Prostaglandin E2, E-Prostanoid 3-Receptors, and Potassium Channels Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 657 - 662. [Abstract] [Full Text] [PDF]

				S. Doi, N. Smedira, and P. A. Murray Pulmonary vasoregulation by endothelin in conscious dogs after left lung transplantation J Appl Physiol, January 1, 2000; 88(1): 210 - 218. [Abstract] [Full Text] [PDF]

				W. Shi, P. Cernacek, F. Hu, and R. P. Michel Endothelin reactivity and receptor profile of pulmonary vessels in postobstructive pulmonary vasculopathy Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2558 - H2564. [Abstract] [Full Text] [PDF]